Caffeine modulates tau phosphorylation and affects Akt signaling in postmitotic neurons

Journal of Molecular Neuroscience

Volumn 43, Issue 3, 2011, Pages 326-332

  Currais, Antonio ^a   Kato, Kiyoko ^b   Canuet, Leonides ^b   Ishii, Ryouhei ^b   Tanaka, Toshihisa ^b   Takeda, Masatoshi ^b   Soriano, Salvador ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Alzheimer's; Caffeine; Cell cycle; Neurodegeneration; Tau

Indexed keywords

APHIDICOLIN; CAFFEINE; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN D1; DNA DIRECTED DNA POLYMERASE DELTA; LITHIUM CHLORIDE; PROTEIN KINASE B; STAUROSPORINE; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN CORTEX; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; MITOSIS; MOLECULAR GENETICS; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CAFFEINE; CELL LINE; HUMANS; NEURONS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 79955789404     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-010-9444-8     Document Type: Article

References (29)

1. Arendash GW, Mori T, Cao C et al (2009) Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. J Alzheimers Dis 17:661-680
2. Bhaskar K, Miller M, Chludzinski A, Herrup K, Zagorski M, Lamb BT (2009) The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events. Mol Neurodegener 4:14
3. Bode AM, Dong Z (2006) The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 247:26-39
4. Currais A, Hortobagyi T, Soriano S (2009) The neuronal cell cycle as a mechanism of pathogenesis in Alzheimer's disease. Aging 1:363-371
5. Dall'Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR (2007) Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice. Exp Neurol 203:241-245 (Pubitemid 44821181)
6. Delobel P, Flament S, Hamdane M et al (2002) Abnormal tau phosphorylation of the Alzheimer-type also occurs during mitosis. J Neurochem 83:412-420 (Pubitemid 35191406)
7. Evans TA, Raina AK, Delacourte A et al (2007) BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. Int J Med Sci 4:140-145 (Pubitemid 46743287)
8. Griffin RJ, Moloney A, Kelliher M et al (2005) Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J Neurochem 93:105-117 (Pubitemid 40463520)
9. Hong M, Chen DC, Klein PS, Lee VM (1997) Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 272:25326-25332 (Pubitemid 27415724)
10. Hoozemans JJ, Veerhuis R, Rozemuller AJ, Arendt T, Eikelenboom P (2004) Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex. Neurobiol Dis 15:492-499 (Pubitemid 38429964)
11. Kruman II, Wersto RP, Cardozo-Pelaez F et al (2004) Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41:549-561 (Pubitemid 38253067)
12. Ksiezak-Reding H, Pyo HK, Feinstein B, Pasinetti GM (2003) Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro. Biochim Biophys Acta 1639:159-168 (Pubitemid 37421423)
13. Lindsay J, Laurin D et al (2002) Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156:445-453 (Pubitemid 34976983)
14. Liu F, Iqbal K, Grundke-Iqbal I, Gong CX (2002) Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. FEBS Lett 530:209-214 (Pubitemid 35248213)
15. Maia L, de Mendonca A (2002) Does caffeine intake protect from Alzheimer's disease? Eur J Neurol 9:377-382
16. Malik B, Currais A, Andres A et al (2008) Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain. Cell Cycle 7:637-646 (Pubitemid 351499003)
17. McShea A, Lee HG, Petersen RB et al (2007) Neuronal cell cycle re-entrymediatesAlzheimer disease-type changes. BiochimBiophys Acta 1772:467-472 (Pubitemid 46400380)
18. Merighi S, Mirandola P, Milani D et al (2002) Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. J Invest Dermatol 119:923-933 (Pubitemid 35340920)
19. Mori Y, Higuchi M, Masuyama N, Gotoh Y (2004) Adenosine A2A receptor facilitates calcium-dependent protein secretion through the activation of protein kinase A and phosphatidylinositol-3 kinase in PC12 cells. Cell Struct Funct 29:101-110 (Pubitemid 40260034)
20. Park KH, Hallows JL, Chakrabarty P, Davies P, Vincent I (2007) Conditional neuronal simian virus 40T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. J Neurosci 27:2969-2978 (Pubitemid 46438995)
21. Preuss U, Mandelkow EM (1998) Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease. Eur J Cell Biol 76:176-184 (Pubitemid 28365356)
22. Ritchie K, Carriere I, de Mendonca A et al (2007) The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology 69:536-545 (Pubitemid 47357260)
23. Sadik G, Tanaka T, Kato K et al (2009) Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation. J Neurochem 108:33-43
24. Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM (1999) Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38:3549-3558
25. Stein TD, Johnson JA (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 22:7380-7388 (Pubitemid 35386337)
26. Tanzi RE, Bertram L (2005) Twentyyears of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120:545-555
27. Wilcox CL, Johnson EM Jr (1988) Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J Virol 62:393-399 (Pubitemid 18064179)
28. Williamson R, Scales T, Clark BR et al (2002) Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases. J Neurosci 22:10-20 (Pubitemid 34033478)
29. Zhou XW, Winblad B, Guan Z, Pei JJ (2009) Interactions between glycogen synthase kinase 3beta, protein kinase B, and protein phosphatase 2A in tau phosphorylation in mouse N2a neuroblastoma cells. J Alzheimers Dis 17:929-937